Patent · US Active

Isoxazole derivatives as inducers of fetal hemoglobin in erythroid precursor cells from beta-thalassemic patients

US11077116B2 · kind B2 · utility

0Cited by

1References

5Claims

0Family size

Assignee

RARE PARTNERS SRL · IT

Inventors

Ilaria Lampronti · Ferrara, IT
Roberto Gambari · Bologna, IT
Daniele Simoni · Ferrara, IT

Key dates

Filing date	Jul 13, 2018
Grant date	Aug 3, 2021
Priority date	—
Expiry date	Jul 31, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention refers to the use of isoxazole derivatives to prepare medicament able to induce fetal hemoglobin (HbF) synthesis in β-thalassemia and sickle cell disease (SCD) patients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.